argenx SE | ARGX - Net Income

Stock Price
661.60
Daily Change
-4.60 -0.69%
Monthly
7.93%
Yearly
22.34%
Q2 Forecast
651.81

argenx SE reported $532.95M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AstraZeneca USD 2.33B 207M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
Qiagen NV USD 107.83M 22.21M Dec/2025
UCB EUR 1.08B 608M Dec/2025